MAPT and neurodegenerative disease: Additionally, two 4R tau species containing MTBDs in the CSF could differentiate AD from other neurodegenerative diseases (PSP, CBD, Pick’s disease, and AGD) but do not distinguish among these non-AD conditions [32].